Remove Access Remove Conditions Remove Media Remove Treatment
article thumbnail

MS patients are being ‘denied’ access to NHS Sativex Says Media Report

Cannabis Law Report

The MS Society has said that thousands of multiple sclerosis patients are being denied access to the approved drug Sativex, which helps improve spasm symptoms in sufferers. Many are finding that despite the treatment being approved, they are being denied access in their area.”. How much longer are we going to have to wait?

Access 105
article thumbnail

The Impact of Medical Marijuana on Mental Health

MMJ Recs

It’s a time for both individuals and organizations to engage in conversations, initiatives, and activities aimed at reducing stigma, increasing understanding, and fostering empathy surrounding mental health conditions. Image by Marcel Strauß on Unsplash.

Marijuana 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ryan’s Law Will Increase Terminally Ill CA Patients’ Access to Cannabis

Veriheal

Gavin Newsom signed a bill known as Ryan’s Law requiring hospitals in the state to allow terminally ill patients access to medical cannabis for treatment and pain relief. hospitals currently prohibit the ingestion of cannabis on-site regardless of the treatment it can provide for patients—particularly those in hospice.

Access 117
article thumbnail

Renewing Medical Marijuana Cards in Arkansas: All You Need to Know

MMJ Recs

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

article thumbnail

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Cannabis Law Report

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

article thumbnail

Three Major Australian Medical Cannabis Companies Fined By The TGA “over claims prescriptions could treat conditions such as cancer and epilepsy”

Cannabis Law Report

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The infringements were for the alleged unlawful advertising of medicinal cannabis products on websites and social media platforms. The Guardian reports. Cannatrek Ltd (22 notices, $293,040) and.

article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105